361 related articles for article (PubMed ID: 27366899)
1. Effect of NADPH-cytochrome P450 reductase on all-trans-retinoic acid efficacy and cytochrome P450 26A1 expression in human myeloid leukaemia HL-60 cells.
Hu L; Lv JF; Zhuo W; Zhang CM; Zhou HH; Fan L
J Pharm Pharmacol; 2016 Sep; 68(9):1193-202. PubMed ID: 27366899
[TBL] [Abstract][Full Text] [Related]
2. Regulation of a highly specific retinoic acid-4-hydroxylase (CYP26A1) enzyme and all-trans-retinoic acid metabolism in human intestinal, liver, endothelial, and acute promyelocytic leukemia cells.
Ozpolat B; Mehta K; Lopez-Berestein G
Leuk Lymphoma; 2005 Oct; 46(10):1497-506. PubMed ID: 16194896
[TBL] [Abstract][Full Text] [Related]
3. all-trans-Retinoic acid-induced expression and regulation of retinoic acid 4-hydroxylase (CYP26) in human promyelocytic leukemia.
Ozpolat B; Mehta K; Tari AM; Lopez-Berestein G
Am J Hematol; 2002 May; 70(1):39-47. PubMed ID: 11994980
[TBL] [Abstract][Full Text] [Related]
4. NADPH-cytochrome P450 reductase is regulated by all-trans retinoic acid and by 1,25-dihydroxyvitamin D3 in human acute myeloid leukemia cells.
Gocek E; Marchwicka A; Bujko K; Marcinkowska E
PLoS One; 2014; 9(3):e91752. PubMed ID: 24642534
[TBL] [Abstract][Full Text] [Related]
5. Anorectal and urinary anomalies and aberrant retinoic acid metabolism in cytochrome P450 oxidoreductase deficiency.
Fukami M; Nagai T; Mochizuki H; Muroya K; Yamada G; Takitani K; Ogata T
Mol Genet Metab; 2010 Jul; 100(3):269-73. PubMed ID: 20409737
[TBL] [Abstract][Full Text] [Related]
6. CRABPs Alter
Yabut KCB; Isoherranen N
Nutrients; 2022 Apr; 14(9):. PubMed ID: 35565751
[TBL] [Abstract][Full Text] [Related]
7. The retinoic acid hydroxylase Cyp26a1 has minor effects on postnatal vitamin A homeostasis, but is required for exogenous
Zhong G; Hogarth C; Snyder JM; Palau L; Topping T; Huang W; Czuba LC; LaFrance J; Ghiaur G; Isoherranen N
J Biol Chem; 2019 Jul; 294(29):11166-11179. PubMed ID: 31167781
[TBL] [Abstract][Full Text] [Related]
8. [Study on the synergic effect of all-trans retinoic acid combined with IFN-alpha on the proliferation and differentiation of HL-60 cells].
Liu CH
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2005 Sep; 21(5):637-9, 642. PubMed ID: 16143075
[TBL] [Abstract][Full Text] [Related]
9. Molecular recognition of CYP26A1 binding pockets and structure-activity relationship studies for design of potent and selective retinoic acid metabolism blocking agents.
Sun B; Song S; Hao CZ; Huang WX; Liu CC; Xie HL; Lin B; Cheng MS; Zhao DM
J Mol Graph Model; 2015 Mar; 56():10-9. PubMed ID: 25541526
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis, and biological evaluation of amide imidazole derivatives as novel metabolic enzyme CYP26A1 inhibitors.
Sun B; Liu K; Han J; Zhao LY; Su X; Lin B; Zhao DM; Cheng MS
Bioorg Med Chem; 2015 Oct; 23(20):6763-73. PubMed ID: 26365710
[TBL] [Abstract][Full Text] [Related]
11. All-Trans Retinoic Acid Activity in Acute Myeloid Leukemia: Role of Cytochrome P450 Enzyme Expression by the Microenvironment.
Su M; Alonso S; Jones JW; Yu J; Kane MA; Jones RJ; Ghiaur G
PLoS One; 2015; 10(6):e0127790. PubMed ID: 26047326
[TBL] [Abstract][Full Text] [Related]
12. Retinoic acid-metabolizing enzyme cytochrome P450 26a1 (cyp26a1) is essential for implantation: functional study of its role in early pregnancy.
Han BC; Xia HF; Sun J; Yang Y; Peng JP
J Cell Physiol; 2010 May; 223(2):471-9. PubMed ID: 20112286
[TBL] [Abstract][Full Text] [Related]
13. Transcript profiling of cytochrome P450 genes in HL-60 human leukemic cells: upregulation of CYP1B1 by all-trans-retinoic acid.
Kawai M; Chen J; Cheung CY; Chang TK
Mol Cell Biochem; 2003 Jun; 248(1-2):57-65. PubMed ID: 12870655
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of topoisomerase IIbeta in myeloid leukemia cell lines leads to activation of apoptosis following all-trans retinoic acid-induced differentiation/growth arrest.
Chikamori K; Hill JE; Grabowski DR; Zarkhin E; Grozav AG; Vaziri SA; Wang J; Gudkov AV; Rybicki LR; Bukowski RM; Yen A; Tanimoto M; Ganapathi MK; Ganapathi R
Leukemia; 2006 Oct; 20(10):1809-18. PubMed ID: 16932348
[TBL] [Abstract][Full Text] [Related]
15. Identification of the fenretinide metabolite 4-oxo-fenretinide present in human plasma and formed in human ovarian carcinoma cells through induction of cytochrome P450 26A1.
Villani MG; Appierto V; Cavadini E; Valsecchi M; Sonnino S; Curley RW; Formelli F
Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6265-75. PubMed ID: 15448016
[TBL] [Abstract][Full Text] [Related]
16. Pharmacogenomic analysis of acute promyelocytic leukemia cells highlights CYP26 cytochrome metabolism in differential all-trans retinoic acid sensitivity.
Quere R; Baudet A; Cassinat B; Bertrand G; Marti J; Manchon L; Piquemal D; Chomienne C; Commes T
Blood; 2007 May; 109(10):4450-60. PubMed ID: 17218384
[TBL] [Abstract][Full Text] [Related]
17. Expression and functional characterization of cytochrome P450 26A1, a retinoic acid hydroxylase.
Lutz JD; Dixit V; Yeung CK; Dickmann LJ; Zelter A; Thatcher JE; Nelson WL; Isoherranen N
Biochem Pharmacol; 2009 Jan; 77(2):258-68. PubMed ID: 18992717
[TBL] [Abstract][Full Text] [Related]
18. The oncogene EVI1 enhances transcriptional and biological responses of human myeloid cells to all-trans retinoic acid.
Steinmetz B; Hackl H; Slabáková E; Schwarzinger I; Smějová M; Spittler A; Arbesu I; Shehata M; Souček K; Wieser R
Cell Cycle; 2014; 13(18):2931-43. PubMed ID: 25486480
[TBL] [Abstract][Full Text] [Related]
19. Physiologically Based Pharmacokinetic Model of All-
Jing J; Nelson C; Paik J; Shirasaka Y; Amory JK; Isoherranen N
J Pharmacol Exp Ther; 2017 May; 361(2):246-258. PubMed ID: 28275201
[TBL] [Abstract][Full Text] [Related]
20. Regulation of CYP26A1 expression by selective RAR and RXR agonists in human NB4 promyelocytic leukemia cells.
Idres N; Marill J; Chabot GG
Biochem Pharmacol; 2005 Jun; 69(11):1595-601. PubMed ID: 15896339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
